IDDM9-region on chromosome 3q has shown suggestive evidence for linkage to type 1 diabetes in some but not all genome scans. We analyzed 22 microsatellite markers in 121 Finnish type 1 diabetes multiplex families across the IDDM9-region. Twopoint maximum LOD scores of 3.4 and 2.5 were detected with markers D3S1589 and D3S3606, respectively. Two markers were further tested for association using the transmission disequilibrium test in 384 Finnish type 1 diabetes simplex families. Marker AFM203wd10 showed association with type 1 diabetes (P ¼ 0.0002 for allele R16). Association was present in families with children carrying the HphI-23 AA risk genotype at IDDM2 but not in families with children carrying protective AT or TT genotypes implying interaction between the two loci. Our data gives credence to earlier findings of linkage in this region and suggests a location for a polymorphism affecting type 1 diabetes susceptibility in the area surrounding AFM203wd10. Genes and Immunity (2006) Keywords: Type 1 diabetes; linkage study; Finnish population; IDDM9; multifactorial inheritance HLA-region genes DQB1-, DQA1-and DRB1 are the major loci (IDDM1) in type 1 diabetes (T1D) susceptibility, where several predisposing and protective alleles and haplotypes have been reported. The HLA-region explains approximately 50% of the genetic background of T1D suggesting additional genetic determinants. In addition to the HLA loci, several candidate genes and regions have been assigned to T1D in numerous wholegenome scans and candidate gene studies. We have tested one of these regions, IDDM9, 1 for linkage and association in the Finnish population. Linkage evidence for the IDDM9-region so far is inconclusive, as only suggestive linkage has been reported. The highest unconditioned maximum LOD score (MLS) (1.1) was reported in a study of 356 UK families 1 but the majority of evidence for this region has come from data sets stratified by HLA status or sex. Davies et al.
HLA-region genes DQB1-, DQA1-and DRB1 are the major loci (IDDM1) in type 1 diabetes (T1D) susceptibility, where several predisposing and protective alleles and haplotypes have been reported. The HLA-region explains approximately 50% of the genetic background of T1D suggesting additional genetic determinants. In addition to the HLA loci, several candidate genes and regions have been assigned to T1D in numerous wholegenome scans and candidate gene studies. We have tested one of these regions, IDDM9, 1 for linkage and association in the Finnish population. Linkage evidence for the IDDM9-region so far is inconclusive, as only suggestive linkage has been reported. The highest unconditioned maximum LOD score (MLS) (1.1) was reported in a study of 356 UK families 1 but the majority of evidence for this region has come from data sets stratified by HLA status or sex. Davies et al. 2 reported an MLS of 1.9 for the marker D3S1303 in sibpairs sharing two HLA alleles identical by descent (IBD). An MLS of 2.4 was observed in a subset of 126 HLA-identical HLA-DR3/DR4 heterozygous sibpairs. 1 Furthermore, an MLS of 2.0 was seen in female sibpairs in the same UK data set using marker D3S1279. 3 A nominal LOD score of 1.05 was observed for 107 Finnish T1D sibpairs at a region located B30 cM upstream of IDDM9 in our earlier study. 4 The region spans B2 cM between markers D3S3620 and D3S3576 and contains an autoimmune candidate locus, the CD86 gene, which is a costimulatory molecule involved in T-cell activation and proliferation via interaction with the T-cell ligands CD28 and CTLA4 (cytotoxic T-lymphocyte-associated antigen 4). An association study of two CD86 SNPs in the Finnish population showed no significant association with T1D 5 implying that CD86 is not the alleged T1D susceptibility gene in this region.
In the present study we reanalyzed the IDDM9 region using 22 microsatellite markers in a region spanning 60 cM around the reported IDDM9-region at 3q12-q25.
The analyzes of the 121 Finnish multiplex T1D families using 22 microsatellite markers in and around the IDDM9-region showed two distinguishable regions of linkage with above nominal MMLS (LOD41.2) (Figure 1 ). Markers D3S1302 and D3S1572 define the more centromeric region of linkage and markers from D3S1551 to D3S3606 the distal region located approximately 22 cM downstream of D3S1572. Two-point LOD scores are expanding the span of nominal significance at the distal region to D3S3720 whereas at the centromeric region marker D3S1572 is the only one showing significance. The highest LOD scores at the region of strongest linkage between the markers D3S3720 and D3S3606 were observed with two-point analysis, MLS ¼ 3.4 for the D3S1589 and MLS ¼ 2.5 for the D3S3606. The highest multipoint LOD scores were also detected with D3S1589 and D3S3606 where D3S3606 showed marginally stronger linkage than the D3S1589 (MMLS ¼ 2.2 and MMLS ¼ 1.8, respectively) ( Figure 1) . None of the HLA or HphI-23 stratified data sets revealed stronger linkage than the complete data set.
Marker AFM203wd10 was associated with T1D in TDT. A global P-value of 0.0004 was detected with the ETDT-test of the TDTPHASE program and alleles R15 and R16 presented allele-wise P-values of 0.0008 and 0.0002 respectively (Table 1) . Association was not present in family trios with healthy children (Table 1) . No evidence for association was found with the markers D3S3584 or D3S1589.
Data sets stratified by the HLA genotypes did not show significantly increased or decreased transmission when compared to complete data set or each other. Data set stratified by the HphI-23 T1D risk genotype AA showed somewhat increased association when compared to the complete data set (Table 1 ), but the difference was not significant. In contrast, the combined data set of protective HphI-23 AT/TT genotypes did not show significant transmission disequilibrium (Table 1) .
Earlier linkage studies have provided evidence, albeit weak, that the 3q13-q25 region could harbor a gene affecting T1D etiology. Our results support these past findings and provide thus far the strongest linkage evidence for T1D susceptibility at the 3q region. Suggestive and close to significant LOD scores were observed with markers separated by 1.2 Mb (D3S1589, D3S3606). LOD scores drop drastically between D3S1589 and D3S3606 but this is probably due to low heterozygosity of the markers AFM203wd10 and D3S3584, which have polymorphic information content (PIC) values of 0.37 and 0.57, respectively compared to PIC values of 0.68 and 0.83 for D3S1589 and D3S3606, respectively. These differences in marker informativity can cause 1.5-4.5 fold differences in power to detect linkage. 6 We found additional evidence for this interval in TDT analysis of an independent set of 348 Finnish family trios. Association was identified with marker AFM203wd10 located 530 kb distal to D3S1589. In contrast, marker D3S3584 situated 700 kb further downstream was not associated thus defining the distal limit for the location of a putative T1D locus. We could not explicitly define the centromeric limit because the marker D3S1589, while also not associated, was less Figure 1 A plot of multipoint (bolded line) and two point (dashed line) maximum LOD scores in the complete data set. The data set used in the sib pair study included 121 Finnish multiplex families and was analyzed with all 22 markers. Samples were collected at pediatric centers treating children affected by T1D in Finland. All subjects with T1D were diagnosed under the age of 15 years according to the WHO criteria and blood samples were collected from the affected children and their parents. The study was approved by the Ethics Committees of the participating hospitals and informed consents were obtained from the study subjects and/or their parents. Microsatellite markers for linkage analysis were chosen based on their location and informativity using online databases. Markers were genotyped using fluorescently labeled PCR primers and automated sequencers ABI 310 (Applied Biosystems, Foster City, USA) and MegaBace 1000 (Amersham Biosciences, Buckinghamshire, UK). Primer sequences and details on thermal conditions and reagents used in PCR and sequencing reactions are available on request. All markers were found to be in Hardy-Weinberg equilibrium in parents. Both data sets were stratified into six groups according to the HLA-DQB1 and INS HphI-23 genotypes. Affected children were genotype-identical in each group within and between families. HLA groups: HLA-DR3/HLA-DR4, HLA-DR3/X (XaDQB1*302), HLA-DR4/X (XaDQB1*201) and sibpairs with other genotypes (non-DR3/non-DR4). INS groups: those carrying the risk genotype AA and those carrying the protective genotypes AT or TT. The MAPMAKER/SIBS 13 computer program was used for calculating multipoint (MMLS) and two-point (MLS) maximum LOD scores using restriction to possible triangle. The loci affecting T1D susceptibility outside the HLA-region are likely to have a recurrence risk ratio for sibs (ls) smaller than 1.4. 14 If locus specific l s of 1.4 is assumed, our data set of 121 sib pairs have 3% power to detect linkage with genome-wide significance (MLS ¼ 3.6) (assuming fully informative marker and y ¼ 0). informative for detecting association than the D3S3584 due to higher number of alleles. Since no significant linkage disequilibrium (LD) was found between AFM203wd10 and D3S1589 or AFM203wd10 and D3S3584 (multi-allelic D 0 ¼ 0.10 and 0.03, respectively), we can assume that the alleged polymorphism affecting T1D susceptibility is located in proximity of the AFM203wd10.
Stratification by genotypes of the IDDM2-marker HphI-23 revealed that association was not present in families stratified by the dominantly protective effect of the T allele positive haplotypes. Conversely, in families homozygous for the predisposing A allele, an association of the same magnitude as in the complete data set was seen. This finding would suggest interaction between the 3q21 region and the insulin gene region in T1D etiology. The HphI-23 AT/TT stratified data set is fairly small and is therefore lacking the statistical power to make definite claims about possible interaction between these two loci.
In contrast to earlier studies, we could not find any clear evidence for HLA-dependent linkage in our data. Even though this does not rule out the possibility of interaction between the loci, it implies that HLA has no major modifying effect on the susceptibility conferred by the alleged 3q21 T1D locus.
Another autoimmune disease, rheumatoid arthritis (RA), has also been linked to this region. 7 This raises the possibility that a common autoimmune factor, involved in both T1D and RA etiology, is encoded by a gene located in this region, which would make our results relevant also for the mapping of RA genes.
Our sib pair data set is underpowered to detect linkage in loci with weak or modest effect. On the other hand, the fact that association in the presence of linkage (TDT) was found in an independent data set with enough power to detect moderate to weak effects with observed significance argues against arbitrary causes explaining the linkage. Linkage found in D3S1589 and D3S3606 could arise from linkage disequilibrium to an associated marker AFM203wd10 but no LD was found between the markers. A spurious association could still result from segregation distortion 8 where transmission ratio is distorted from the null hypothesis of 50% at the wholepopulation level. We tested, however, TDT with 212 healthy sibs of the affected children used in the TDT analysis, and no association was present, which excludes transmission ratio distortion as the source of association.
We report suggestive linkage to T1D at the locus 3q21 using 121 Finnish sib pair families. The finding was replicated in an independent set of 348 Finnish caseparent trios using TDT. Before any definitive claims can be made about the role of this locus in T1D etiology, more replication studies are needed. Due to the power limitations attached to the affected relative pair linkage methods, future efforts in confirming the finding and subsequently fine mapping the alleged locus should be directed primarily to association methods using SNPs. A data set of 348 Finnish simplex families with parents and one affected child was analyzed with three markers (D3S1589, AFM203wd10 and D3S3584). Samples were collected at pediatric centers treating children affected by T1D in Finland. All subjects with T1D were diagnosed under the age of 15 years according to the WHO criteria and blood samples were collected from the affected children and their parents. The study was approved by the Ethics Committees of the participating hospitals and informed consents were obtained from the study subjects and/or their parents. Microsatellite markers chosen specifically for TDT (AFM203wd10 and D3S3584) were close to linked markers and had only three alleles to accommodate to the requirements of association analysis. AFM203wd10 was analyzed also in 212 family trios with healthy children. Unaffected children were healthy siblings of the affected children in the family trios used in the transmission disequilibrium test (TDT). Markers were genotyped using fluorescently labeled PCR primers and automated sequencer MegaBace 1000 (Amersham Biosciences, Buckinghamshire, UK). Primer sequences and details on thermal conditions and reagents used in PCR and sequencing reactions are available on request. All markers were found to be in Hardy-Weinberg equilibrium in parents.
To sort out the number of consecutive dinucleotide CA-repeat units in the three alleles of the AFM203wd10, homozygotes for each allele were sequenced. The alleles comprise 15, 16 or 17 consecutive repeat units (named R15, R16 and R17, respectively by us). Both data sets were stratified into six groups according to the HLA-DQB1 and INS HphI-23 genotypes. Affected children were genotype-identical in each group within and between families. HLA groups: HLA-DR3/HLA-DR4, HLA-DR3/X (XaDQB1*302), HLA-DR4/X (XaDQB1*201) and sibpairs with other genotypes (non-DR3/non-DR4). INS groups: those carrying the risk genotype AA and those carrying the protective genotypes AT or TT. The TDTPHASE program of the Unphased package 9 was used for testing association by TDT. Powermarker software was used for assessing multi-allelic D 0 LD values. 10 If we assume a genotypic risk ratio (g) of 2.0 for the 3q21 disease gene allele (gp2.0 equals lso1.3) 11 and disease allele frequency of 0.1, we can expect a P-value of 8.3
À5 for TDT-statistic in our data set of 348 families (assuming actual disease polymorphism or complete LD to disease gene allele). 12 If higher disease allele frequencies are assumed, the power is increased. Disease allele frequencies of 0.3 and 0.5 would produce P-values of 6.1 À8 and 3.4
À8
, respectively, in our data set. 
